Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 8
2014 5
2015 10
2016 9
2017 7
2018 5
2019 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Differential predictive factors for cardiovascular events in patients with or without cancer history.
Sueta D, Tabata N, Ikeda S, Saito Y, Ozaki K, Sakata K, Matsumura T, Yamamoto-Ibusuki M, Murakami Y, Jodai T, Fukushima S, Yoshida N, Kamba T, Araki E, Iwase H, Fujii K, Ihn H, Kobayashi Y, Minamino T, Yamagishi M, Maemura K, Baba H, Matsui K, Tsujita K. Sueta D, et al. Among authors: yamamoto ibusuki m. Medicine (Baltimore). 2019 Nov;98(44):e17602. doi: 10.1097/MD.0000000000017602. Medicine (Baltimore). 2019. PMID: 31689764 Free PMC article.
Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
Sueta A, Yamamoto Y, Tomiguchi M, Takeshita T, Yamamoto-Ibusuki M, Iwase H. Sueta A, et al. Among authors: yamamoto ibusuki m. Oncotarget. 2017 Jul 22;8(41):69934-69944. doi: 10.18632/oncotarget.19482. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050253 Free PMC article.
Targeted therapies for ER+/HER2- metastatic breast cancer.
Yamamoto-Ibusuki M, Arnedos M, André F. Yamamoto-Ibusuki M, et al. BMC Med. 2015 Jun 9;13:137. doi: 10.1186/s12916-015-0369-5. BMC Med. 2015. PMID: 26059247 Free PMC article. Review.
Factors involved in early lenvatinib dose reduction: a retrospective analysis.
Suyama K, Tomiguchi M, Takeshita T, Sueta A, Yamamoto-Ibusuki M, Shimokawa M, Yamamoto Y, Iwase H. Suyama K, et al. Among authors: yamamoto ibusuki m. Med Oncol. 2018 Jan 31;35(3):19. doi: 10.1007/s12032-018-1088-5. Med Oncol. 2018. PMID: 29387983
ESR1 and PIK3CA mutational status in serum and plasma from metastatic breast cancer patients: A comparative study.
Takeshita T, Yamamoto Y, Yamamoto-Ibusuki M, Tomiguchi M, Sueta A, Iwase H. Takeshita T, et al. Among authors: yamamoto ibusuki m. Cancer Biomark. 2018;22(2):345-350. doi: 10.3233/CBM-171161. Cancer Biomark. 2018. PMID: 29689710
APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer.
Fujiki Y, Yamamoto Y, Sueta A, Yamamoto-Ibusuki M, Goto-Yamaguchi L, Tomiguchi M, Takeshita T, Iwase H. Fujiki Y, et al. Among authors: yamamoto ibusuki m. Oncotarget. 2018 Jul 17;9(55):30513-30526. doi: 10.18632/oncotarget.25495. eCollection 2018 Jul 17. Oncotarget. 2018. PMID: 30093965 Free PMC article.
Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling.
Goto-Yamaguchi L, Yamamoto-Ibusuki M, Yamamoto Y, Fujiki Y, Tomiguchi M, Sueta A, Takeshita T, Iwase H. Goto-Yamaguchi L, et al. Among authors: yamamoto ibusuki m. Breast Cancer Res Treat. 2018 Nov;172(2):353-362. doi: 10.1007/s10549-018-4933-5. Epub 2018 Aug 27. Breast Cancer Res Treat. 2018. PMID: 30151737
Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer.
Takeshita T, Yamamoto Y, Yamamoto-Ibusuki M, Tomiguchi M, Sueta A, Murakami K, Iwase H. Takeshita T, et al. Among authors: yamamoto ibusuki m. Mol Cancer. 2018 Feb 26;17(1):67. doi: 10.1186/s12943-018-0808-y. Mol Cancer. 2018. PMID: 29482551 Free PMC article.
High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.
Miyasato Y, Shiota T, Ohnishi K, Pan C, Yano H, Horlad H, Yamamoto Y, Yamamoto-Ibusuki M, Iwase H, Takeya M, Komohara Y. Miyasato Y, et al. Among authors: yamamoto ibusuki m. Cancer Sci. 2017 Aug;108(8):1693-1700. doi: 10.1111/cas.13287. Epub 2017 Jul 3. Cancer Sci. 2017. PMID: 28574667 Free PMC article.
Lenvatinib, an oral multi-kinases inhibitor, -associated hypertension: Potential role of vascular endothelial dysfunction.
Sueta D, Suyama K, Sueta A, Tabata N, Yamashita T, Tomiguchi M, Takeshita T, Yamamoto-Ibusuki M, Yamamoto E, Izumiya Y, Kaikita K, Yamamoto Y, Hokimoto S, Iwase H, Tsujita K. Sueta D, et al. Among authors: yamamoto ibusuki m. Atherosclerosis. 2017 May;260:116-120. doi: 10.1016/j.atherosclerosis.2017.03.039. Epub 2017 Mar 30. Atherosclerosis. 2017. PMID: 28390289 Clinical Trial.
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback